QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Quantify RWE Kick-off: Nordic Collaboration in Action!
This week, we are delighted to welcome our colleagues from Denmark and Finland to Stockholm as we kick off the fall period for the Real-World Evidence & Analytics unit. It’s a great opportunity for meetings, planning, and strengthening our overall collaboration and evidence generation.
💡Cross-office moments like these enable us to deliver trusted, local insights at scale – while having a lot of fun during the way!
[…]
Quantify joined expert panel on Finnish health data!
Last week, our very own Mathias Lilja participated in an expert panel about the possibilities of Finland for RWE research in a Fingenious event about Finnish Health data ecosystem. The event was full of excellent use cases of Finnish data so far and a brave vision ahead to mold it even better.
📊 In his key notes, Mathias pointed out just a couple of the key differentiating factors where Finland […]
Quantify is joining the Finnish Health Data Ecosystem event today!
👉 Meet up with our team in Finland to connect, Ville Perälä, Katja Nolvi and Eleni Kampanellou PhD.
🗨 Mathias Lilja is also joining a panel of experts to discuss how Finnish RWE compares with other Nordic countries and beyond.
Want to bring your treatment to the Finnish market? Then you need to understand what PALKO is and what it does.
In Finland, market access for hospital drugs and medical technologies isn’t just about regulatory approval, it’s about PALKO.
The Finnish Council for Choices in Health Care (Palveluvalikoimaneuvosto, PALKO) acts as a critical gatekeeper in the publicly funded healthcare system. Before a new inpatient pharmaceutical or health technology can be reimbursed or widely adopted, it must pass through PALKO’s recommendation and the associated […]
